Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 1 Date: 19 Jul 2024
Reviewer's report:
The author has taken my suggestions into account and made appropriate revisions to the paper.
This paper deserves to be accepted.
However, please correct "Clostridium difficile" in the title to "Clostridioides difficile."
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 1 Date: 19 Jul 2024
Reviewer's report:
The author has taken my suggestions into account and made appropriate revisions to the paper.
This paper deserves to be accepted.
However, please correct "Clostridium difficile" in the title to "Clostridioides difficile."
Please review this paper.
user
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 1 Date: 19 Jul 2024
Reviewer's report:
The author has taken my suggestions into account and made appropriate revisions to the paper.
This paper deserves to be accepted.
However, please correct "Clostridium difficile" in the title to "Clostridioides difficile."
assistant